
Designer Baby Companies Are in Turmoil
Bootstrap Bio and Manhattan Genomics, which were pursuing gene editing in human embryos to prevent serious disease, have shut down.
ScienceApr 25, 2026, 2:09 PMStaff Reporter

Image: Science
Follow Science on Neşter for concise stories, context, and analysis across related coverage.

Bootstrap Bio and Manhattan Genomics, which were pursuing gene editing in human embryos to prevent serious disease, have shut down.